Congenital heart defect (CHD) encompasses structural problems affecting the heart, including walls of the heart, the valves of the heart, and the arteries and veins near the heart; blood flow through the heart is frequently affected. Also described as congenital heart disease, CHD is the most common type of birth defect and is thought to have a significant genetic component. The most serious defects are described as critical congenital heart defects or critical congenital heart disease (CCHD).
Many of the CHD models in Drosophila involve genes that encode histone modifying proteins that are required for epigenetic regulation of development processes. See links in 'Related diseases' section.
[updated Nov. 2018 by FlyBase; FBrf0222196]
Genetic causes of congenital heart disease also account for many of the comorbidities seen with increased frequency in congenital heart disease patients, including neurodevelopmental disability, pulmonary disease, arrhythmia, renal disease, heart failure and an increased incidence of malignancy. (Simmons and Brueckner, 2017; pubmed:28872494).
A number of well studied syndromes, including DiGeorge syndrome, Williams-Beuren syndrome, Alagille syndrome, Noonan syndrome, and Holt-Oram syndrome, include congenital heart defect (Pierpont et al., 2007; pubmed:17519398).
A congenital heart defect is a problem with the structure of the heart; it is the most common type of birth defect. The defects can involve the walls of the heart, the valves of the heart, and the arteries and veins near the heart. They can disrupt the normal flow of blood through the heart: the blood flow can slow down, go in the wrong direction or to the wrong place, or be blocked completely (https://medlineplus.gov/congenitalheartdefects.html).
Defects range from simple, which might cause no problems, to complex, which can cause life-threatening complications. The most serious defects are categorized as critical congenital heart defects (CCHD). CCHD is life threatening and requires intervention in infancy; approximately 18 out of 10,000 babies are born with CCHD (https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/PEHDIC/Pages/Newborn-Screening-for-CCHD.aspx).
Congenital heart defects (CHTD) are among the most common congenital defects, occurring with an incidence of 8/1,000 live births. The etiology of CHTD is complex, with contributions from environmental exposure, chromosomal abnormalities, and gene defects. [from MIM:306955; 2018.11.13]
A large portion of congenital heart disease is thought to have a significant genetic contribution; at this time a genetic cause can be identified in approximately 35% of patients (Simmons and Brueckner, 2017; pubmed:28872494).